暢由聯盟(01039.HK):終止視作出售於一間附屬公司的股權
格隆匯7月4日丨暢由聯盟(01039.HK)發佈公吿,有關公司間接非全資附屬公司分海與Sendlink訂立認購協議,分海擬向Sendlink配發及發行不少於3567萬美元但不多於4280萬美元或不少於6107.88萬股但不多於7328.77萬股認購股份。由於認購協議的先決條件於最後截止日期(即2022年6月30日)前並未獲達成或獲分海或Sendlink豁免(倘適用或視情況而定),認購協議已於2022年7月1日自動終止,將不會向投資者發行認購股份。根據認購協議的條款,認購協議的一方不得根據認購協議對其他一方提出任何性質的申索(於終止前已產生的任何權利及義務除外)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.